Remarketing
Why Remarketing Belongs in Every CDMO’s Marketing Plan
Emilee Kudla
Pharma's Almanac
PAO-07-25-NI-12Jul 24, 2025
Industrial Vacuums
Delfin Enhances Pharmaceutical Manufacturing with Advanced Containment and Conveying Systems
Dimitri Di Salvo; Frank Intrieri Jr.
Delfin Industrial Corporation
PAO-04-24-PHEX-25Jun 17, 2025
Flexibility
Flexible CDMO Solutions — Reducing Risk and Accelerating Time to Market
Sheetal Muley, Ph.D.; Justin Lacombe, Ph.D.
Experic
PAO-04-25-CL-06May 23, 2025
HPAPI
BioDuro Opens Shanghai Laboratory for Highly Potent Compound Synthesis
BioDuro
PR-03-25-NI-07Mar 25, 2025
HPAPIs
An Introduction to HPAPIs and Cytotoxic Drugs
Roots Analysis
PAO-04-23-CL-04Apr 25, 2023
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
Olon
PR-M09-22-06Sep 27, 2022
Complex Chemistry
Solving Complex Chemical Problems Across All Phases of NCE Programs
Luigi Trussardo
Olon
PAO-10-21-CL-11Oct 21, 2021
Process Development
Designing More Sustainable Small Molecule API Manufacturing Processes
Marko Salo; Arne Grumann
Fermion
PAO-09-21-CL-05Sep 16, 2021
High Potency
Streamlining Highly Potent Drug Commercialization
Norbert Straub; Uwe Korn; Robert Klehr
Fareva
PAO-04-21-CL-04Apr 19, 2021
HPAPI
A Successful Approach for Managing Unexpected Increases in Potency for HPAPIs
Daniela Kovats
Fareva
PAO-01-21-CL-01Jan 11, 2021
Small Molecule
The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic
Pierre Luzeau, Ph.D.
Seqens
PAP-Q4-20-CL-025Dec 09, 2020
Specialized OSD Services
Avara Pharmaceutical Services: Specialization with a Client-Centric Approach
Deborah A. Graham
Avara Pharmaceutical Services
PAP-Q4-20-CL-003Dec 09, 2020
SEQENS Inaugurates HPAPI Unit
Seqens
PR-M08-20-NI-47Aug 28, 2020
Expansion
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Catalent
PR-M08-20-NI-13Aug 07, 2020
HPAPIs
Essentials of an Industry-Leading CDMO Partner for Highly Potent Projects
Brian P. Haney, Ph.D.
Curia (formerly AMRI)
PAP-Q2-20-CL-031Jul 01, 2020
Investment
Should You Choose a Commercial HPAPI Manufacturer for Your Clinical Program?
David Bastie; George Hlass
Fareva
PAO-11-2019-CL-001Dec 06, 2019
Global Network
Applying an Established and Continuously Upgraded Global Network for CDMO Services
Lorraine Hill
Aspen Pharma
PAP-Q3-19-CL-002-2034Oct 28, 2019
HPAPI
Successful US FDA Inspection of Asymchem Tianjin 1 HPAPI Development and Manufacturing Facility
Asymchem
PR-M03-19-NI-077Mar 27, 2019
HPAPI
Investing in the Future of Potent Compounds
Frederic Desdouits
Seqens
PAP-Q1-2019-CL-028Mar 12, 2019
Lyophilization
Flow Sciences, Inc. Partners with Three Companies to Contain Lyophilization Process of New HPAPI
Flow Sciences, Inc.
PR-M01-19-NI-052Jan 15, 2019